文献速递药疹与重症皮肤不良反应

全球抗生素相关Stevens-Johnson综合征与中毒性表皮坏死松解症的患病率:系统综述与Meta分析

Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Dermatol · 2023-01-01

该系统综述与Meta分析检索MEDLINE和Embase至2022年2月22日,纳入64项研究,其中38项报告患者水平关联的研究(2917例患者)用于Meta分析。抗生素相关SJS/TEN的合并比例为28%(95%CI 24%-33%),其中磺胺类占32%(95%CI 22%-44%),青霉素类22%(95%CI 17%-28%),头孢菌素类11%(95%CI 6%-17%),氟喹诺酮类4%(95%CI 1%-7%),大环内酯类2%(95%CI 1%-5%)。

要点

  • 全球范围内,抗生素与超过四分之一的SJS/TEN病例相关,合并比例为28%(95%CI 24%-33%)。
  • 磺胺类抗生素是最重要的关联药物,占抗生素相关SJS/TEN病例的32%(95%CI 22%-44%)。
  • 作者认为这些发现凸显了抗生素管理、临床医生教育和意识以及权衡抗生素选择与疗程风险获益评估的重要性。

核心结论

  • 在全球所有病例系列的系统综述与Meta分析中,抗生素与超过四分之一的SJS/TEN病例相关,磺胺类抗生素仍是最重要的关联药物。
  • 作者认为这些发现凸显了抗生素管理、临床医生教育和意识以及权衡抗生素选择与疗程风险获益评估的重要性。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE和Embase数据库自建库至2022年2月22日的实验性和观察性研究。
  • 纳入64项研究,其中38项描述患者水平关联的研究(2917例患者)纳入Meta分析,采用随机效应模型。
  • 采用Joanna Briggs Institute清单评估偏倚风险,采用GRADE方法评定证据确定性,并进行了亚组分析以探索异质性。

主要发现

  • 抗生素相关SJS/TEN的合并比例为28%(95%CI 24%-33%),证据确定性为中等。
  • 在抗生素相关SJS/TEN中,磺胺类与32%(95%CI 22%-44%)的病例相关,青霉素类为22%(95%CI 17%-28%),头孢菌素类为11%(95%CI 6%-17%),氟喹诺酮类为4%(95%CI 1%-7%),大环内酯类为2%(95%CI 1%-5%)。
  • Meta分析中存在统计学显著异质性,亚组分析按洲可部分解释该异质性。
  • 采用Joanna Briggs Institute病例系列清单评估的总体偏倚风险为低。

关键数值与推荐

  • 抗生素相关SJS/TEN的合并比例为28%(95%CI 24%-33%),证据确定性为中等。
  • 磺胺类与32%(95%CI 22%-44%)的抗生素相关SJS/TEN病例相关。
  • 青霉素类与22%(95%CI 17%-28%)的抗生素相关SJS/TEN病例相关。
  • 头孢菌素类与11%(95%CI 6%-17%)的抗生素相关SJS/TEN病例相关。
  • 氟喹诺酮类与4%(95%CI 1%-7%)的抗生素相关SJS/TEN病例相关;大环内酯类与2%(95%CI 1%-5%)相关。

临床怎么用

  • 作者认为这些发现凸显了抗生素管理、临床医生教育和意识以及权衡抗生素选择与疗程风险获益评估的重要性。

局限性

  • Meta分析中存在统计学显著异质性,亚组分析按洲可部分解释该异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Antibiotics are an important risk for Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), which are the most severe types of drug hypersensitivity reaction with a mortality rate up to 50%. To our knowledge, no global systematic review has described antibiotic-associated SJS/TEN. OBJECTIVE: To evaluate the prevalence of antibiotics associated with SJS/TEN worldwide. DATA SOURCES: The MEDLINE and Embase databases were searched for experimental and observational studies that described SJS/TEN risks since database inception to February 22, 2022. STUDY SELECTION: Included studies adequately described SJS/TEN origins and specified the antibiotics associated with SJS/TEN. DATA EXTRACTION AND SYNTHESIS: Two reviewers (E.Y.L. and C.K.) independently selected the studies, extracted the data, and assessed the risk of bias. A meta-analysis using a random-effects model was performed in the studies that described patient-level associations. Subgroup analyses were performed to explore the heterogeneity. The risk of bias was assessed using the Joanna Briggs Institute checklist, and the certainty of evidence was rated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. MAIN OUTCOMES AND MEASURES: Prevalence of antibiotic-associated SJS/TEN was presented as pooled proportions with 95% CIs. RESULTS: Among the 64 studies included in the systematic review, there were 38 studies that described patient-level associations; the meta-analysis included these 38 studies with 2917 patients to determine the prevalence of single antibiotics associated with SJS/TEN. The pooled proportion of antibiotics associated with SJS/TEN was 28% (95% CI, 24%-33%), with moderate certainty of evidence. Among antibiotic-associated SJS/TEN, the sulfonamide class was associated with 32% (95% CI, 22%-44%) of cases, followed by penicillins (22%; 95% CI, 17%-28%), cephalosporins (11%; 95% CI, 6%-17%), fluoroquinolones (4%; 95% CI, 1%-7%), and macrolides (2%; 95% CI, 1%-5%). There was a statistically significant heterogeneity in the meta-analysis, which could be partially explained in the subgroup analysis by continents. The overall risk of bias was low using the Joanna Briggs Institute checklist for case series. CONCLUSION AND RELEVANCE: In this systematic review and meta-analysis of all case series, antibiotics were associated with more than one-quarter of SJS/TEN cases described worldwide, and sulfonamide antibiotics remained the most important association. These findings highlight the importance of antibiotic stewardship, clinician education and awareness, and weighing the risk-benefit assessment of antibiotic choice and duration.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Lee EY, Knox C, Phillips EJ, et al. Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. JAMA Dermatol. 2023. PMID: 36790777. doi:10.1001/jamadermatol.2022.6378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。